Decision Diagnostics Stock Analysis
| DECN Stock | USD 0.0001 0.00 0.00% |
Decision Diagnostics is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Decision Diagnostics stock analysis is to determine its intrinsic value, which is an estimate of what Decision Diagnostics is worth, separate from its market price. There are two main types of Decision Diagnostics' stock analysis: fundamental analysis and technical analysis.
The Decision Diagnostics stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Decision Diagnostics is usually not traded on Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. Decision Stock trading window is adjusted to America/New York timezone.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Decision Stock Analysis Notes
The company recorded a loss per share of 0.02. Decision Diagnostics had not issued any dividends in recent years. The entity had 1.1:1 split on the 28th of December 2011. Decision Diagnostics Corp. develops smart phone based electronic medical record technologies. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California. Decision Diagnostics operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 6 people. To learn more about Decision Diagnostics call Keith Berman at 805 446 1973 or check out https://www.decisiondiagnostics.co.Decision Diagnostics Investment Alerts
| Decision Diagnostics generated a negative expected return over the last 90 days | |
| Decision Diagnostics has some characteristics of a very speculative penny stock | |
| Decision Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Decision Diagnostics currently holds 2.93 M in liabilities with Debt to Equity (D/E) ratio of 9.05, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Decision Diagnostics has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Decision Diagnostics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.98 M. Net Loss for the year was (29.67 M) with profit before overhead, payroll, taxes, and interest of 462.23 K. | |
| Decision Diagnostics currently holds about 210.85 K in cash with (1.4 M) of positive cash flow from operations. | |
| Decision Diagnostics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: What analysts say about Cardio Diagnostics Holdings Inc. Equity Warrant stock - High-yield market plays - Jammu Links News |
Decision Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 35.79 K.Decision Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (14.05) | (13.34) | |
| Return On Capital Employed | (2.61) | (2.48) | |
| Return On Assets | (4.72) | (4.49) | |
| Return On Equity | (70.55) | (67.03) |
Management Efficiency
Decision Diagnostics has return on total asset (ROA) of (0.2122) % which means that it has lost $0.2122 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (81.6052) %, meaning that it created substantial loss on money invested by shareholders. Decision Diagnostics' management efficiency ratios could be used to measure how well Decision Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 20th of July 2025, Return On Tangible Assets is likely to grow to -13.34. In addition to that, Return On Capital Employed is likely to grow to -2.48. At this time, Decision Diagnostics' Other Current Assets are very stable compared to the past year. As of the 20th of July 2025, Total Current Assets is likely to grow to about 2.5 M, while Total Assets are likely to drop about 5.2 M.| Last Reported | Projected for Next Year | ||
| Tangible Book Value Per Share | (0.01) | (0.01) | |
| Enterprise Value Over EBITDA | (2.65) | (2.79) | |
| Price Book Value Ratio | 8.93 | 6.06 | |
| Enterprise Value Multiple | (2.65) | (2.79) | |
| Price Fair Value | 8.93 | 6.06 | |
| Enterprise Value | 6.4 M | 4.1 M |
Decision Diagnostics showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Technical Drivers
Decision Diagnostics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Decision Diagnostics Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Simple Moving Average indicator is calculated by adding the closing price of Decision Diagnostics for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Decision Diagnostics short-term fluctuations and highlight longer-term trends or cycles.
Decision Diagnostics Outstanding Bonds
Decision Diagnostics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Decision Diagnostics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Decision bonds can be classified according to their maturity, which is the date when Decision Diagnostics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Decision Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Decision Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Decision shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Decision Diagnostics. By using and applying Decision Stock analysis, traders can create a robust methodology for identifying Decision entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (13.49) | (14.17) | |
| Operating Profit Margin | (0.96) | (1.01) | |
| Net Loss | (13.49) | (14.17) | |
| Gross Profit Margin | 0.23 | 0.18 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Decision Diagnostics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.